Trial Profile
Analysis of correlation between raltegravir plasma concentrations and single nucleotide polymorphisms (SNPs) of ABCB1 and ABCG2 genes in HIV +ve patients treated with raltegravir
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 14 Feb 2015 New trial record